- February 10, 2021
- Organized By:
The FDA Office of Minority Health and Health Equity (OMHHE) in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) will host a virtual public workshop: "Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease" on Wednesday, February 10, 2021 from 10:00 AM - 3:00 PM ET.
This event aims to advance attendees' understanding of the following:
- Leveraging patient experience data and community/system approaches to inform care, drug development and overall research agenda to improve patient outcomes and reduce health inequities for diverse communities with diabetes and chronic kidney disease (CKD).
- Explore barriers to diversity in clinical trials for CKD and diabetes and strategies to improve diversity in clinical trials.
- Utilization of real-world data to inform strategies and decision making on the management of diabetes and CKD.
This workshop supports the Office of Minority Health and Health Equity's (OMHHE) mission; the 21st Century Cures Act to understand patient perspectives; and the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA Section 907), an effort to advance inclusion of racial and ethnic minority populations in clinical trials.
For More Information:
If you have any additional questions about this workshop, please contact email@example.com.